Previous 10 | Next 10 |
It's been a while since I went through the whole vaccine landscape (I've been putting it off!), but there's a lot to catch up on. I'm going to incorporate some slightly reworked material from my July post in the introduction to each vaccine class, for reference, but everything on the candida...
Eastman Kodak (NYSE: KODK ) +44% on D.E.Shaw stake . More news on: Eastman Kodak Company, Priority Technology Holdings, Inc., Zoom Video Communications, Inc., Stocks on the move, , Read more ...
MediciNova (NASDAQ: MNOV ) updates investors on the advancement of its intranasal SARS-CoV-2 vaccine utilizing a viral vector derived from the recombinant human parainfluenza virus type 2 (hPIV2) called BC-PIV, developed by Mie University and BioComo. More news on: MediciNova, Inc., He...
LA JOLLA, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced development progress on its intranasal SARS-CoV-2 vaccin...
American Virtual Cloud Technologies (NASDAQ: AVCT ) +105% . on agreement to buy Ribbon's Kandy Communications business. More news on: American Virtual Cloud Technologies, Inc., ADiTx Therapeutics, Inc., Tivity Health, Inc., Stocks on the move, , Read more ...
MediciNova (NASDAQ: MNOV ) announces positive results from a Phase 2 clinical trial evaluating MN-166 (ibudilast) for the treatment of alcohol use disorder (AUD). The results were presented virtually at the American Psychological Association Annual Meeting. More news on: MediciNova, In...
LA JOLLA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Principal Investigator, Lara Ray...
LA JOLLA, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova will participate in the Mo...
MediciNova (NASDAQ: MNOV ) : Q2 net loss of $44.1M Shares down 8% premarket. 10-Q More news on: MediciNova, Inc., Earnings news and commentary, Healthcare stocks news,
Boxlight (NASDAQ: BOXL ) -27% after pricing equity offering. More news on: Boxlight Corporation, Global Eagle Entertainment Inc., Sypris Solutions, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Company to rededicate efforts toward updating stakeholders on corporate vision, strategy, and ongoing activities LA JOLLA, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market o...
LA JOLLA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a Notice of Allowance from the U.S....
LA JOLLA, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova’s collaborator, Gilbert Youssef, M.D....